V
ISSUER//CIK 0001003929
VIA Pharmaceuticals, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K29.4 KBVIA Pharmaceuticals, Inc.Mar 1, 12:23 PM ET·0000950123-10-019034
- 8-K35.8 KBVIA Pharmaceuticals, Inc.May 1, 9:29 AM ET·0000950134-09-009035
- 8-K61.0 KBVIA Pharmaceuticals, Inc.Feb 3, 10:22 AM ET·0000950134-09-001682
- 8-K454.3 KBVIA Pharmaceuticals, Inc.Dec 23, 3:32 PM ET·0000950134-08-022662
- 8-K38.2 KBVIA Pharmaceuticals, Inc.Dec 23, 11:04 AM ET·0000950134-08-022631
- 8-K2.3 MBVIA Pharmaceuticals, Inc.Jan 22, 3:46 PM ET·0000950149-08-000007
- 8-K34.4 KBVIA Pharmaceuticals, Inc.Dec 19, 1:21 PM ET·0000950134-07-025737
- 46.2 KBVIA Pharmaceuticals, Inc.Dec 19, 12:31 PM ET·0001209191-07-070899
- 46.2 KBVIA Pharmaceuticals, Inc.Dec 19, 12:30 PM ET·0001209191-07-070898
- 46.1 KBVIA Pharmaceuticals, Inc.Dec 19, 12:30 PM ET·0001209191-07-070896
Insiders
10- ATWOOD ROBERT TCFO, Executive VP
- Bagnall MarkDirector
- BOSTON SCIENTIFIC CORP10% Owner
- CALLICUTT JACK WVP-Finance&Admin, Chf Acct Off
- CHIANG YAWEN LSVP - Chief Scientific Officer
- FALKENBERG ERIC NDirector
- GILSTRAP JAMES CDirector
- HOWARD DAVID TDirector
- LARSON JOHN RANDOLPHDirector
- OLUKOTUN ADEOYE YChief Medical Officer
Tickers
No tickers on record
Addresses
business
750 BATTERY STREET SUITE 330
SAN FRANCISCO, CA, 94111
mailing
750 BATTERY STREET SUITE 330
SAN FRANCISCO, CA, 94111
Former Names
- CORAUTUS GENETICS INC2007-06-20
- GENSTAR THERAPEUTICS CORP2002-12-19
- UROGEN CORP2000-02-14